MedPage Today on MSN1d
The Evolving Role of MRD in Managing Multiple Myeloma"MRD testing has revolutionized our approach to multiple myeloma, allowing us to detect even the smallest traces of cancer ...
Medpage Today on MSN2d
Assessing Patient Fitness for Transplant in Multiple MyelomaAssessing patient fitness involves more than evaluating chronological age, noted Brandon Blue, MD, of the Moffitt Cancer ...
A treatment approach harnessing bispecific antibodies to target cancerous cells unlocks new possibilities for patients, says ...
Cesar Rodriguez, MD, discussed several key aspects of talquetamab use in the treatment of relapsed/refractory multiple ...
Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be ...
The Connecticut resident said she’s a woman of strong faith who believes in the power of prayer and that’s all that helped to ...
The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R ...
Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...
clinicaltrialsarena on MSN5d
GSK reports positive outcomes from Phase III multiple myeloma treatment trialGSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...
News Medical on MSN5d
Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stagesMultiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback